You must log in to view this page.

Chemomab Therapeutics Ltd. – Filings and Transcripts

NASDAQ: CMMB
Share price (8/17/26): $1.92
Market cap (8/17/26): $13.8 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 12/31/24 FY 2024

ended 12/31/23 FY 2023

ended 03/31/23 Q1

ended 12/31/22 FY 2022

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Updated info for already-effective prospectus

Prospectus supplement for primary offering

Prospectus supplement

Shelf registration

Ownership Filter

Touchstone Global Investments Pty Ltd

HBM Healthcare Investments (Cayman) Ltd.

Melincoff Gwen A

News Filter

Chemomab Therapeutics and Precision Medicine Pioneer Scipher Medicine Announce Merger Agreement to Advance Nebokitug in an AI-Powered Phase 2 Trial in Rheumatoid Arthritis

Material disclosure

Announces First Quarter 2026 Financial Results and Provides Corporate Update

Material disclosure

Material disclosure

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Preliminary proxy

Definitive proxy

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness